How many boxes of pirfenidone/asrex per course of treatment?

Pirfenidone/Pirfenidone is an important drug used to treat idiopathic pulmonary fibrosis (IPF). In clinical practice, patients' medication dosage and course of treatment usually need to be adjusted according to individual conditions to achieve the best therapeutic effect. Generally speaking, the amount used in a course of treatment depends on several factors, including the patient's specific condition, the doctor's prescription, and the patient's tolerance of the drug.

According to the drug's instructions, the usual recommended dose of pirfenidone is 801 mg three times daily. During the initial stages of treatment, doctors usually adopt a gradually increasing dosage regimen to help patients better adapt to the medication. This plan may start with taking 267mg each time, continue for seven days and then increase to 534mg. After the 15th day, increase to the recommended maintenance dose, which is 801mg three times a day. Such adjustments can help reduce the occurrence of adverse reactions, especially during the initial stages of drug use. Therefore, patients may require lower doses during the first few weeks of treatment and then gradually increase to the recommended maintenance dose.

For a standard treatment cycle, if it is calculated as 801mg three times a day, each timethe patient needs 2403mg of drug per day. Converting this into the number of boxes, considering that each box contains 54 100mg pills of pirfenidone, based on the required daily dose, a 14-day course of treatment requires approximately 6 boxes of the drug. The specific number needs to be determined based on the patient's adaptation and the doctor's advice.

In addition, patients need to undergo regular follow-up visits while using pirfenidone to evaluate the treatment effect and monitor possible adverse reactions. During the follow-up process, the doctor will decide whether to continue using the drug or adjust the medication plan based on the patient's specific response. This personalized approach to treatment is critical to improving patients’ quality of life and slowing disease progression.